2018 expert consensus on the management of adverse effects of antiplatelet therapy for acute coronary syndrome in Taiwan

Yi Heng Li, Chih Yuan Fang, I. Chang Hsieh, Wei Chun Huang, Tsung Hsien Lin, Shih Hsien Sung, Chiung Zuan Chiu, Chiung Jen Wu, Kou Gi Shyu, Po Yuan Chang, Ching Chang Fang, Tse Min Lu, Ching Pei Chen, Wei Chen Tai, Chau Chyun Sheu, Kai Che Wei, Yi Hsiu Huang, Hsing Mei Wu, Juey Jen Hwang

研究成果: Review article同行評審

14 引文 斯高帕斯(Scopus)

摘要

Antiplatelet therapy is a key component in the treatment of acute coronary syndrome (ACS). The management of ACS has evolved considerably over recent years with the development of new and more potent antiplatelet agents. Clinical trials on ACS have demonstrated that potent antiplatelet agents can more effectively reduce cardiovascular events. However, there is a tipping point between safety and efficacy, beyond which the risk of bleeding and other adverse effects can outweigh the benefits of antiplatelet therapy. Striking a balance between safety and efficacy remains a major challenge. A consensus meeting of an expert panel composed of Taiwanese experts was held to provide recommendations for the management of adverse effects in patients with ACS receiving antiplatelet therapy. The common adverse effects of antiplatelet therapy include upper gastrointestinal bleeding, ecchymosis, hematuria, epistaxis and ticagrelor-related dyspnea. In this study, a literature review of these adverse events was performed and recommendations for the management were made.

原文English
頁(從 - 到)201-210
頁數10
期刊Acta Cardiologica Sinica
34
發行號3
DOIs
出版狀態Published - 2018 五月

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

指紋 深入研究「2018 expert consensus on the management of adverse effects of antiplatelet therapy for acute coronary syndrome in Taiwan」主題。共同形成了獨特的指紋。

引用此